HK1092090A1 - Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases - Google Patents

Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases

Info

Publication number
HK1092090A1
HK1092090A1 HK06112754.5A HK06112754A HK1092090A1 HK 1092090 A1 HK1092090 A1 HK 1092090A1 HK 06112754 A HK06112754 A HK 06112754A HK 1092090 A1 HK1092090 A1 HK 1092090A1
Authority
HK
Hong Kong
Prior art keywords
extract
treatment
composition
radix salviae
salviae miltiorrhizae
Prior art date
Application number
HK06112754.5A
Other languages
English (en)
Inventor
Xijun Yan
Naifeng Wu
Zhengliang Ye
Xu Li
Zhixin Guo
Na Zhao
Original Assignee
Tasly Pharmaceutical Group Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34621020&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1092090(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CNB031552757A external-priority patent/CN100391486C/zh
Priority claimed from CNB2004100198381A external-priority patent/CN100411641C/zh
Application filed by Tasly Pharmaceutical Group Co filed Critical Tasly Pharmaceutical Group Co
Publication of HK1092090A1 publication Critical patent/HK1092090A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK06112754.5A 2003-08-28 2006-11-20 Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases HK1092090A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB031552757A CN100391486C (zh) 2003-08-28 2003-08-28 复方丹参滴丸在制备治疗阿司匹林抵抗性心血管疾病的药物中的应用
CNB2004100198381A CN100411641C (zh) 2004-06-30 2004-06-30 一种滴丸剂在制备治疗阿司匹林抵抗药物中的应用
PCT/CN2004/000989 WO2005049058A1 (fr) 2003-08-28 2004-08-26 Radix salviae miltiorrhizae, extrait et composition destines au traitement des maladies de resistance a l'aspirine

Publications (1)

Publication Number Publication Date
HK1092090A1 true HK1092090A1 (en) 2007-02-02

Family

ID=34621020

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06112754.5A HK1092090A1 (en) 2003-08-28 2006-11-20 Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases

Country Status (14)

Country Link
US (2) US20070071837A1 (fr)
EP (1) EP1658879B1 (fr)
JP (1) JP2007504099A (fr)
KR (1) KR101210405B1 (fr)
AU (1) AU2004290484B8 (fr)
CA (1) CA2537300C (fr)
DK (1) DK1658879T3 (fr)
EA (1) EA010910B1 (fr)
ES (1) ES2405599T3 (fr)
HK (1) HK1092090A1 (fr)
MY (1) MY143282A (fr)
NO (1) NO335203B1 (fr)
PT (1) PT1658879E (fr)
WO (1) WO2005049058A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005044289A2 (fr) * 2003-11-07 2005-05-19 Cognis France, S.A.S. Extrait vegetal et son utilisation pharmaceutique et cosmetique
MY147497A (en) * 2005-10-12 2012-12-14 Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia Process for preparation of labisia pumila extract
GB2439046B (en) * 2006-06-16 2010-12-08 Phynova Ltd Antiviral product
WO2010111935A1 (fr) * 2009-03-30 2010-10-07 天津天士力制药股份有限公司 Nouveau composé d'acide salvianolique l, procédé de préparation et d'utilisation
US20120148685A1 (en) * 2009-06-10 2012-06-14 Engergy4Life AG Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders
CN102160872A (zh) 2010-02-23 2011-08-24 天津天士力制药股份有限公司 复方丹参滴丸胶囊
MY172154A (en) * 2012-08-29 2019-11-14 Biotropics Malaysia Berhad Composition for cognition and cosmetic purposes and use of said composition for preparing an agent
CN103099896B (zh) * 2013-01-06 2014-10-01 车艳艳 治疗心脑血管疾病的药茶
CN103169777B (zh) * 2013-02-07 2014-09-10 江苏七○七天然制药有限公司 一种治疗心血管疾病的中药胶囊

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104286D0 (en) * 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders
WO2001031052A1 (fr) * 1999-10-25 2001-05-03 Colorado Coagulation Consultants Metabolite de thromboxane b2 et procedes pour reguler l'action des plaquettes liee a l'aspirine
JP2001354579A (ja) * 2000-06-15 2001-12-25 Lion Corp 抗炎症化粧料
US8486464B2 (en) * 2000-12-22 2013-07-16 Tasly Pharmaceutical Group Co. Ltd. Herbal composition for angina pectoris, method to prepare same and uses thereof
BRPI0116589B1 (pt) * 2000-12-22 2018-07-03 Tasly Pharmaceutical Group Co., Ltd. Composição herbal para angina pectoris, método para prepará-la e uso desta
US20050037094A1 (en) * 2003-07-31 2005-02-17 Xijun Yan Composition for heart disease, its active ingredients, method to prepare same and uses thereof

Also Published As

Publication number Publication date
US20080305189A1 (en) 2008-12-11
DK1658879T3 (da) 2013-05-13
US20070071837A1 (en) 2007-03-29
EA200600471A1 (ru) 2006-08-25
WO2005049058A1 (fr) 2005-06-02
PT1658879E (pt) 2013-04-08
MY143282A (en) 2011-04-15
AU2004290484A1 (en) 2005-06-02
EP1658879B1 (fr) 2013-02-20
EA010910B1 (ru) 2008-12-30
NO20060832L (no) 2006-02-21
AU2004290484B2 (en) 2010-03-25
CA2537300A1 (fr) 2005-06-02
KR101210405B1 (ko) 2012-12-10
KR20070017944A (ko) 2007-02-13
ES2405599T3 (es) 2013-05-31
EP1658879A1 (fr) 2006-05-24
CA2537300C (fr) 2013-07-30
JP2007504099A (ja) 2007-03-01
WO2005049058A8 (fr) 2005-08-11
AU2004290484B8 (en) 2010-05-13
NO335203B1 (no) 2014-10-20
EP1658879A4 (fr) 2008-11-26

Similar Documents

Publication Publication Date Title
HK1092090A1 (en) Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases
DE60206137D1 (de) Kräuterpflanzen enthaltende artzneimittel
PL375621A1 (en) Pharmaceutical compositions comprising flavonoids and menthol
WO2006032091A3 (fr) Composition a base d'herbes medicinales
IL189500A (en) 4, 2-Diaminopyrimidines are preserved in position 5, containing pharmaceutical preparations and using them to prepare a drug for the treatment of 3x2p receptor mediated diseases and 2/3 x2p
IL194550A (en) Isolated antibodies or their fragments that bind to human protein tyrosine phosphate in a cell, their pharmaceutical preparations and their use
UA99685C2 (ru) Композиции для предотвращения или облегчения желудочно-кишечных заболеваний
WO2006053049A3 (fr) Composition phytotherapeutique phy906 et son utilisation en chimiotherapie
CL2007003155A1 (es) Compuestos derivados de 3,7-diazabiciclo[3.3.0]octano o 3,7-diazabiciclo[3.3.1]nonano, moduladores de receptores nicotinicos neuronales; composicion farmaceutica; y uso en el tratamiento de trastornos del snc.
BRPI0512352A (pt) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimiocinas
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
DOP2007000053A (es) Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo
IL183928A0 (en) Bcma polypeptides, their preparation and pharmaceutical compositions containing them
BRPI0514124B8 (pt) anticorpos monoclonais específicos para il-4 humana, seu uso, composição farmacêutica que os comprende e polinucleotídeos
CL2007003190A1 (es) Compuestos derivados de arilsulfonil-pirrolidinas; procedimiento de obtencion; composicion farmaceutica; y uso en la prevencion o tratamiento de enfermedades tales como psicosis, depresion, alzheimer, entre otras.
WO2018025080A3 (fr) Compositions pour améliorer l'activité cérébrale
PT1838716E (pt) Di-hidrato de pamoato de olanzapina
WO2006087629A3 (fr) Composition de medicament antipsychotique a delitement rapide
BRPI0418749A (pt) composição herbal
WO2007071840A3 (fr) Composes a base de quatre cycles aromatiques, preparation et utilisations
WO2004001068A3 (fr) Utilisation de modulateurs de la phosphatase pp2a pour le traitement de troubles mentaux
WO2006055404A3 (fr) Composes pour cibler des mecanismes impliques dans la progression de l'avc
TW200607520A (en) Use of Salvia, its extracts and composition thereof for treating aspirin resistance
BR0318652A (pt) composição de ervas para o tratamento de disfunções gastrointestinais

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: DELETION OF INVENTOR: ZHENG, JUN

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230826